dorzolamide-timolol
Showing 1 - 25 of 247
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Monterrey (Dorzolamide-timolol-brimonidine and latanoprost,
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide-timolol-brimonidine and latanoprost
- Dorzolamide-timolol and latanoprost
-
Monterrey, MexicoServicios Médicos y de Investigación Clínica InspirePharma S. de
Dec 22, 2021
Glaucoma Trial in Gainesville (timolol maleate and dorzolamide HCl)
Completed
- Glaucoma
- timolol maleate and dorzolamide hydrochloride
-
Gainesville, FloridaUniversity of Florida
Dec 1, 2021
Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)
Recruiting
- Primary Open-angle Glaucoma
- PRO-122
- +6 more
-
Bogotá, Bogotá D.C., Colombia
- +1 more
Dec 22, 2021
Open-angle Glaucoma Trial in Thessaloniki (Drug: dorzolamide/timolol, Drug: latanoprost/timolol, dorzolamide/timolol and
Completed
- Open-angle Glaucoma
- Drug: dorzolamide/timolol
- +3 more
-
Thessaloniki, GreeceGlaucoma Unit, A University Dept of Ophthalmology
Dec 16, 2020
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Glaucoma, Ocular Surface Disease Trial (tafluprost, tafluprost and dorzolamide/timolol)
Completed
- Glaucoma
- Ocular Surface Disease
- tafluprost
- tafluprost and dorzolamide/timolol
- (no location specified)
Dec 16, 2020
Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial
Completed
- Neovascular Age-related Macular Degeneration
- Wet Macular Degeneration
- Dorzolamide-timolol
- Artificial tears
-
Palo Alto, California
- +4 more
Jun 5, 2020
Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)
Active, not recruiting
- Glaucoma
- Latanoprost
- +7 more
-
Miami, FloridaBascom Palmer Eye Institute - University of Miami
Oct 7, 2021
Wet Macular Degeneration, Age-related Macular Degeneration, Diabetic Macular Edema Trial in Philadelphia (Dorzolamide-timolol)
Completed
- Wet Macular Degeneration
- +3 more
- Dorzolamide-timolol
-
Philadelphia, PennsylvaniaWills Eye Hospital / Mid Atlantic Retina
Dec 1, 2019
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Montemorelos (dorzolamide-timolol-brimonidine)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
-
Montemorelos, Nuevo Leon, MexicoInstituto de la Visión. Hospital Universitario La Carlota. Unive
Jun 6, 2019
Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +
Completed
- Primary Open Angle Glaucoma of Both Eyes
- Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
- Cosopt eye drops, 20 mg/mL + 5 mg/mL
-
Kazan, Russian FederationRepublican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023
Primary Open Angle Glaucoma, Ocular Hypertension Trial (PRO-122, Krytantek Ofteno®)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- PRO-122
- Krytantek Ofteno®
- (no location specified)
Nov 20, 2019
Glaucoma Trial in Guadalajara (PRO-122, Krytantek Ofteno®)
Completed
- Glaucoma
- PRO-122
- Krytantek Ofteno®
-
Guadalajara, Jalisco, MexicoUnidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 12, 2019
Macular Hole, Retinal Detachment Trial in Philadelphia (Dorzolamide 2%-timolol 0.5% topical eyedrops)
Completed
- Macular Hole
- Retinal Detachment
- Dorzolamide 2%-timolol 0.5% topical eyedrops
-
Philadelphia, PennsylvaniaWills Eye Institute
Aug 13, 2019
Glaucoma, Open-Angle Trial (Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol
Completed
- Glaucoma, Open-Angle
- Brimonidine Tartrate
- +5 more
- (no location specified)
May 24, 2019
Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed
Completed
- Glaucoma
- fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
- fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
-
Indianapolis, Indiana(unnamed)
Apr 10, 2019
Glaucoma, Ocular Surface Disease Trial in Thessaloniki (Assessment of ocular surface staining (Oxford score 0-15 scale), mean
Completed
- Glaucoma
- Ocular Surface Disease
- Assessment of ocular surface staining (Oxford score 0-15 scale)
- mean diurnal intraocular pressure-lowering
-
Thessaloniki, GreeceUniversity Department of Ophthalmology
Dec 16, 2020
Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)
Recruiting
- Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
- Topical Timolol
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 14, 2023
Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System
Recruiting
- Cataract
- +2 more
- Bimatoprost Implant System (High Dose)
- +4 more
-
Glendale, ArizonaArizona Advanced Eye Research Institute
Nov 8, 2023
Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)
Not yet recruiting
- Glaucoma Open-Angle Primary
- Ocular Hypertension
- H-1337 0.6%
- +3 more
-
Albany, GeorgiaDixon Eye Care
Jun 12, 2023
Infantile Hemangioma Trial in Houston (Propranolol three times a day, Propranolol twice a day, Timolol)
Recruiting
- Infantile Hemangioma
- Propranolol three times a day
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jul 28, 2022
Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Nebivolol Ophthalmic Suspension 1 Percent
- +3 more
-
Newport Beach, CaliforniaSite 0012
Jul 18, 2022
Acne Scars - Mixed Atrophic and Hypertrophic Trial (microneedling, microneedling with topical timolol 0.5%)
Not yet recruiting
- Acne Scars - Mixed Atrophic and Hypertrophic
- microneedling
- microneedling with topical timolol 0.5%
- (no location specified)
Oct 25, 2022